News
London, 22 May 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces that preclinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback